Ultrasound Historical Financial Summary

Pharmaceutical Diagnostics Historical Financial Summary EGE HealthCare Revenue $2.0B $2.0B $1.8B $1.5B $1.5B 2019A 2020A 2021A I 2021 3Q YTD 2022 3Q YTD Segment EBIT Margin 36.5% 34.9% 34.3% 28.3% 27.7% Key Drivers Growing Procedural Demand Over Next Decade Rise of Molecular Imaging Strong Recurring Revenue and Margins Theranostics Creating Growth Opportunity 2019A 2020A 2021A I 2021 3Q YTD 2022 3Q YTD © 2022, General Electric Company. Proprietary information. All rights reserved. 78

View entire presentation